Search Results - "Padayattil Jose', S."

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome by PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., BANZATO, A., PADAYATTIL JOSE, S., ILICETO, S.

“…See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary.  Background: The characteristics and the clinical course of antiphospholipid…”
Get full text

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk by Pengo, V., Ruffatti, A., Tonello, M., Cuffaro, S., Banzato, A., Bison, E., Denas, G., Padayattil Jose, S.

“…Summary Background Determination of lupus anticoagulant (LA), anticardiolipin (aCL) and β2‐Glycoprotein 1 (aβ2GP1) antibodies is mandatory to classify patients…”
Get full text

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial by Pengo, V, Banzato, A, Bison, E, Zoppellaro, G, Padayattil Jose, S, Denas, G

“…Background New oral anticoagulants may simplify long-term therapy in conditions requiring anticoagulation. Rivaroxaban is a direct factor Xa inhibitor that has…”
Get full text

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile by Pengo, V., Ruffatti, A., Del Ross, T., Tonello, M., Cuffaro, S., Hoxha, A., Banzato, A., Bison, E., Denas, G., Bracco, A., Padayattil Jose, S.

“…Summary Background The revised classification criteria for the antiphospholipid syndrome state that antiphospholipid (aPL) antibodies (lupus anticoagulant…”
Get full text

APS - Diagnostics and challenges for the future by Pengo, V, Bison, E, Zoppellaro, G, Padayattil Jose, S, Denas, G, Hoxha, A, Ruffatti, A, Banzato, A

“…Abstract Diagnosis of antiphospholipid syndrome (APS) is essentially based on the detection of circulating antiphospholipid (aPL) antibodies. Progress have…”
Get full text

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs) by Padayattil Jose, S., Banzato, A., Carraro, P., Haleh, A., Rossi, K., Nante, G., Denas, G., Zoppellaro, G., Pengo, V.

“…Non–vitamin K antagonist oral anticoagulants (NOACs) do not need routine laboratory monitoring but measurement of drug concentration is important in emergency…”
Get full text

Laboratory testing for antiphospholipid syndrome by Pengo, V., Banzato, A., Bison, E., Denas, G., Zoppellaro, G., Bracco, A., Padayattil Jose, S., Hoxha, A., Ruffatti, A.

“…Summary This is a practical report on laboratory tests for the diagnosis of antiphospholipid syndrome (APS). After a general definition of APS, this study…”
Get full text

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA) by Pengo, V, Denas, G, Bison, E, Banzato, A, Padayattil Jose, S, Gresele, P, Marongiu, F, Erba, N, Veschi, F, Ghirarduzzi, A, De Candia, E, Montaruli, B, Marietta, M, Testa, S, Barcellona, D, Tripodi, A

“…Abstract Objective Anti-prothrombin (aPT) antibodies have been found in Lupus Anticoagulant (LA) positive patients. Their prevalence and relative contribution…”
Get full text

Antiphospholipid syndrome: critical analysis of the diagnostic path by Pengo, V., Banzato, A., Bison, E., Denas, G., Padayattil Jose, S., Ruffatti, A.

“…Antiphospholipid syndrome (APS) is diagnosed in the presence of vascular thrombosis or pregnancy morbidity occurring in patients with circulating…”
Get full text

Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study by Denas, G., Padayattil Jose, S., Gresele, P., Erba, N., Testa, S., De Micheli, V., Quintavalla, R., Poli, D., Bracco, A., Fierro, T., Iliceto, S., Pengo, V.

“…The combination of oral anticoagulants with dual antiplatelet therapy (DAT) in patients undergoing percutaneous coronary intervention with stent implantation…”
Get full text

Correct laboratory approach to APS diagnosis and monitoring by Pengo, V, Banzato, A, Denas, G, Jose, S. Padayattil, Bison, E, Hoxha, A, Ruffatti, A

“…Abstract Triple positivity (positive Lupus Anticoagulant, anticardiolipin and anti β2-glycoptrotein I antibodies) identifies the pathogenic autoantibody (anti…”
Get full text

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles by Pengo, V, Ruffatti, A, Tonello, M, Hoxha, A, Bison, E, Denas, G, Padayattil Jose, S, Zoppellaro, G, Bracco, A, Banzato, A

“…Abstract Background Determination of the three recommended tests for the diagnosis of antiphospholipid syndrome [Lupus Anticoagulant (LA), anticardiolipin…”
Get full text

458Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation by Denas, G, Costa, G, Ferroni, E, Gennaro, N, Fedeli, U, Corti, M C, Zoppellaro, G, Padayattil Jose, S, Pengo, V

“…Abstract Introduction Anticoagulation therapy is central for the management of stroke in patients with non-valvular atrial fibrillation (NVAF). Persistence…”
Get full text

Antiphospholipid syndrome: antibodies to Domain 1 of [beta]2-glycoprotein 1 correctly classify patients at risk by Pengo, V, Ruffatti, A, Tonello, M, Cuffaro, S, Banzato, A, Bison, E, Denas, G, Padayattil Jose, S

“…Summary Background Determination of lupus anticoagulant (LA), anticardiolipin (aCL) and [beta]2-Glycoprotein 1 (a[beta]2GP1) antibodies is mandatory to…”
Get full text

Long-term use of vitamin K antagonists in patients with atrial fibrillation and cancer incidence: a pharmaco-epidemiological study by Denas, G., Pengo, V., Joppi, R., Cinconze, E., Mezzalira, L., Pase, D., Poggiani, C., Rossi, E., Padayattil Jose, S., Prandoni, P.

Get full text

Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: accuracy, feasibility, reproducibility and reference values by Badano, L. P., Muraru, D., Mihaila, S., Haertel-Miglioranza, M., Padayattil-Jose, S., Ucci, L., Dal Bianco, L., Peluso, D., Cucchini, U., Iliceto, S.

Get full text

Oral Abstract session New insights in heart muscle diseases: 13/12/2013, 16:30-18:00 Location: Bursa by Tsang, W., Abduch, C., Salgo, I., Appareti, K., Ackerman, W., Cruz, V., Lima, M., Tsutsui, J., Mathias, W., Lang, R., Teske, A., Mast, T. P., Groeneweg, J., Te Riele, A., Van Der Heijden, J., Velthuis, B., Hauer, R., Doevendans, P., Cramer, M., Cautela, J., Krastevich, M., Michel, N., Saby, L., Copel, C., Hubert, S., Avierinos, J., Thuny, F., Guieu, R., Habib, G., Muraru, D., Calore, C., Badano, L., Melacini, P., Mihaila, S., Naso, P., Casablanca, S., Ortile, A., Padayattil Jose', S., Iliceto, S., Hasselberg, N., Saberniak, J., Berge, K., Edvardsen, T., Haugaa, K.

Get full text

Poster session Thursday 12 December - AM: 12/12/2013, 08:30-12:30 Location: Poster area by Abdovic, E., Abdovic, S., Hristova, K., Katova, T., Gocheva, N., Pavlova, M., Gurzun, M. M., Ionescu, A., Canpolat, U., Yorgun, H., Sunman, H., Sahiner, L., Kaya, E., Ozer, N., Tokgozoglu, L., Kabakci, G., Aytemir, K., Oto, A., Gonella, A., D'ascenzo, F., Casasso, F., Conte, E., Margaria, F., Grosso Marra, W., Frea, S., Morello, M., Bobbio, M., Gaita, F., Seo, H., Lee, S., Lee, J., Yoon, Y., Park, E., Kim, H., Park, S., Lee, H., Kim, Y., Sohn, D., Nemes, A., Domsik, P., Kalapos, A., Orosz, A., Lengyel, C., Forster, T., Enache, R., Muraru, D., Popescu, B., Calin, A., Nastase, O., Botezatu, D., Purcarea, F., Rosca, M., Beladan, C., Ginghina, C., Piasentini, E., Mihaila, S., Padayattil Jose', S., Peluso, D., Ucci, L., Naso, P., Puma, L., Iliceto, S., Badano, L., Cikes, M., Jakus, N., Sutherland, G., Haemers, P., D'hooge, J., Claus, P., Yurdakul, S., Oner, F., Direskeneli, H., Sahin, T., Cengiz, B., Ercan, G., Bozkurt, A., Aytekin, S., Osa Saez, A. M., Rodriguez-Serrano, M., Lopez-Vilella, R., Buendia-Fuentes, F., Domingo-Valero, D., Quesada-Carmona, A., Miro-Palau, V., Arnau-Vives, M., Palencia-Perez, M., Rueda-Soriano, J., Lipczynska, M., Piotr Szymanski, P., Anna Klisiewicz, A., Lukasz Mazurkiewicz, L., Piotr Hoffman, P., Kim, K., Cho, S., Ahn, Y., Jeong, M., Cho, J., Park, J., Chinali, M., Franceschini, A.

Get full text